Covered recipient · General Payments record
MARCUS L WILLIAMS
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$22,304.27
- Reported across 143 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,200.00 | 1 |
| Food and Beverage | $372.97 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,200.00 | 1 |
| CVRx Inc. | $149.35 | 1 |
| Acerta Pharma LLC | $120.29 | 1 |
| SCPHARMACEUTICALS INC. | $21.67 | 1 |
| MEDLINE INDUSTRIES LP | $18.46 | 1 |
| Esperion Therapeutics, Inc. | $16.57 | 1 |
| Amgen Inc. | $16.14 | 1 |
| PFIZER INC. | $16.04 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.14 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111739972 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.29 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105826749 | CMS |
| CVRx, Inc. | $149.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140962850 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101751367 | CMS |
| Esperion Therapeutics, Inc. | $16.57 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129460050 | CMS |
| Medline Industries LP | $18.46 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144136344 | CMS |
| Novartis Pharmaceuticals Corporation | $1,200.00 | 05/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1087441898 | CMS |
| PFIZER INC. | $16.04 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131502662 | CMS |
| SCPHARMACEUTICALS INC. | $21.67 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132298105 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.